Trial
NCT04333407
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Imperial College London
Collaborators
—
Condition
COVID-19
Intervention
Aspirin 75mg
Why stopped
Difficulty in recruiting eligible participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-18